1. Home
  2. CYRX vs NEWT Comparison

CYRX vs NEWT Comparison

Compare CYRX & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CYRX

CryoPort Inc.

HOLD

Current Price

$10.05

Market Cap

419.3M

Sector

Health Care

ML Signal

HOLD

Logo NewtekOne Inc.

NEWT

NewtekOne Inc.

HOLD

Current Price

$12.78

Market Cap

395.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYRX
NEWT
Founded
1999
1998
Country
United States
United States
Employees
1100
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
419.3M
395.5M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CYRX
NEWT
Price
$10.05
$12.78
Analyst Decision
Strong Buy
Buy
Analyst Count
9
3
Target Price
$12.94
$15.33
AVG Volume (30 Days)
399.7K
225.4K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
5.97%
EPS Growth
156.22
N/A
EPS
1.40
N/A
Revenue
$176,177,000.00
N/A
Revenue This Year
$11.06
N/A
Revenue Next Year
$8.45
$12.45
P/E Ratio
$7.19
$5.99
Revenue Growth
N/A
N/A
52 Week Low
$5.21
$9.51
52 Week High
$11.45
$14.91

Technical Indicators

Market Signals
Indicator
CYRX
NEWT
Relative Strength Index (RSI) 71.38 64.88
Support Level $9.18 $12.64
Resistance Level $10.23 $14.91
Average True Range (ATR) 0.42 0.38
MACD 0.18 0.23
Stochastic Oscillator 90.10 97.93

Price Performance

Historical Comparison
CYRX
NEWT

About CYRX CryoPort Inc.

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

About NEWT NewtekOne Inc.

NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.

Share on Social Networks: